Utilities and disutilities for type 2 diabetes treatment-related attributes (Q80633837)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Utilities and disutilities for type 2 diabetes treatment-related attributes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

3

Nicole Yurgin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

2

Kristina S Boye

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Louis S Matza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jessica Brewster-Jordan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Sally Mannix

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Jodi M Shorr

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Beth L Barber

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

19 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

published in

Quality of Life Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

1251-1265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11136-007-9226-0

2 January 2020

exact match

0 references

cites work

A cost utility analysis of treatment options for gallstone disease: methodological issues and results.

1 reference

12 December 2020

Methodological issues of patient utility measurement. Experience from two clinical trials.

1 reference

12 December 2020

Reliability and validity of the appraisal of diabetes scale

1 reference

12 December 2020

Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study

1 reference

12 December 2020

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

1 reference

12 December 2020

Fear of hypoglycemia in type 1 (insulin-dependent) diabetic patients.

1 reference

12 December 2020

A consistency test of the time trade-off

1 reference

12 December 2020

Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data

1 reference

12 December 2020

Valuing health-related quality of life in diabetes

1 reference

12 December 2020

A comparison of the health utilities indices Mark 2 and Mark 3 in type 2 diabetes.

1 reference

12 December 2020

Safety profile of repaglinide as used in general practice in England: results of a prescription-event monitoring study

1 reference

12 December 2020

The management of the obese diabetic patient

1 reference

12 December 2020

Weight gain during insulin therapy in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

1 reference

12 December 2020

Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life?

1 reference

12 December 2020

Quality of life in epilepsy: comparison of four preference measures.

1 reference

12 December 2020

1 reference

12 December 2020

The relationship between glycemic control and health-related quality of life in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom

1 reference

12 December 2020

Health state preference assessment in diabetic peripheral neuropathy

1 reference

12 December 2020

Comparison of the rating scale and the standard gamble in measuring patient preferences for outcomes of gallstone disease

1 reference

12 December 2020

Patients' health-related quality-of-life and health state values for motor neurone disease/amyotrophic lateral sclerosis.

1 reference

12 December 2020

Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes

1 reference

12 December 2020

Subjective health values of individuals with diabetes in Japan: comparison of utility values with the SF-36 scores

1 reference

12 December 2020

A computer simulation model of diabetes progression, quality of life, and cost

1 reference

12 December 2020

The impact of obesity on health-related quality-of-life in the general adult US population.

1 reference

12 December 2020

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

The standard gamble method: what is being measured and how it is interpreted

1 reference

12 December 2020

A comparison of the EQ-5D and SF-6D across seven patient groups

1 reference

12 December 2020

Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes

1 reference

12 December 2020

Fear of hypoglycemia in the parents of children and adolescents with diabetes: maladaptive or healthy response?

1 reference

12 December 2020

1 reference

12 December 2020

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62).

1 reference

12 December 2020

Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications

1 reference

12 December 2020

Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report

1 reference

12 December 2020

Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster).

1 reference

12 December 2020

Fear of hypoglycemia: relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus

1 reference

12 December 2020

Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma

1 reference

12 December 2020

Body mass index and quality of well-being in a community of older adults

1 reference

12 December 2020

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

12 December 2020

Discrepancies between chained and classic utilities induced by anchoring with occasional adjustments

1 reference

12 December 2020

Coping with Type II diabetes: the patient's perspective.

1 reference

12 December 2020

Patients' utilities for cancer treatments: a study of the chained procedure for the standard gamble and time tradeoff.

1 reference

12 December 2020

Incorporating utility-based quality-of-life assessment measures in clinical trials. Two examples

1 reference

12 December 2020

Performance of two measures of general health-related quality of life, the EQ-5D and the RAND-36 among critically ill patients.

1 reference

12 December 2020

What value health?: A review of health state values used in early technology assessments for NICE.

1 reference

12 December 2020

Validity and Reliability of the General Well-Being Schedule with Northern Plains American Indians Diagnosed with Type 2 Diabetes Mellitus

1 reference

12 December 2020

Valuing temporary and chronic health states associated with breast screening.

1 reference

12 December 2020

Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes

1 reference

12 December 2020

Health utility estimation

1 reference

12 December 2020

Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire.

1 reference

12 December 2020

Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72).

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Treatment of diabetes in patients with severe obesity

1 reference

12 December 2020

Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma.

1 reference

12 December 2020

Estimating the effect of changes in body mass index on health state preferences

1 reference

12 December 2020

Health state utilities in gastroesophageal reflux disease patients with heartburn: a study in Germany and Sweden.

1 reference

12 December 2020

[The Quality of Life Questionnaire EQ-5D: modelling and norm values for the general population]

1 reference

12 December 2020

Preferences for health outcomes and cost-utility analysis

1 reference

12 December 2020

Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity

1 reference

12 December 2020

Measurement of health state utilities for economic appraisal

1 reference

12 December 2020

Utilities and quality-adjusted life years

1 reference

12 December 2020

1 reference

12 December 2020

Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine

1 reference

12 December 2020

The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making

1 reference

12 December 2020

Orlistat for the treatment of obesity: rapid review and cost-effectiveness model

1 reference

12 December 2020

10.1007/S11136-007-9226-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17638121%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference